Arna stock zacks
Arena Pharmaceuticals, Inc. ARNA and privately-held Beacon Discovery entered into strategic multi-year partnership, which is named Project Cabrillo, to develop novel therapies targeting G protein-coupled receptors ("GPCR") to treat immune and inflammatory indications. Arena Pharmaceuticals, Inc. (ARNA) reported its last quarter results on 03/14/2017. This Company belongs to Medical sector. In the last trading session, The Company traded 1.98 Million shares. The Stock Market opened sessions at 1.45 and closed at 1.41. There was a stock decrease by -2.76 percent. ARNA Stock News and Research Articles - Arena Pharmaceuticals : latest news, headlines and research articles. What's going on at Arena Pharmaceuticals (NASDAQ:ARNA)? View breaking news headlines for ARNA stock from trusted media outlets at MarketBeat. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group. TheStreet Ratings updates stock ratings daily.
Arena Pharmaceuticals (ARNA) Upgraded to Buy: Here's Why. 07-25 zacks.com Arena Pharmaceuticals (ARNA - Free Report) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. ARNA
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and Yesterday it was reported that a Director at Arena Pharma (ARNA – Research Report), Randall Woods, exercised options to sell 3,046 ARNA shares at $32.50 a share, for a total transaction value of $142.3K. Following Randall Woods’ last ARNA Sell transaction on April 01, 2015, the stock climbed by 3.2%. This is Woods’ first transaction Three analysts have rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company’s stock. Arena Pharmaceuticals has an average rating of “Hold” and an average price target of $64.20. Shares of NASDAQ ARNA opened at $46.28 on Wednesday. 7/29/2019 · Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Arena Pharmaceuticals, Inc. (ARNA) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research We are expecting an inline return from the stock in the next few months. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Arena Pharmaceuticals, Inc. (ARNA): Free Stock Analysis Report To read this article on Zacks.com click here. Analyst Ratings for Arena Pharmaceuticals (ARNA) provide recommendations made by outside industry experts.
ARNA, Arena Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines
Issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online. Easily share your publications and get them in front of Issuu’s millions of monthly readers. In 1984 Kessler joined the American Stock Exchange and became the vice president of corporate communications, supervising a staff of 25. Plc (Nasdaq:AMRN) has 298 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Thagard, The Brain and the Meaning of Life, 194; See also James Blair, Derek Mitchell, and Karina Blair, The Psychopath: Emotion and the Brain (Blackwell, 2005). 53 Jeffrey Zacks, Flicker: Your Brain on Movies (Oxford University Press, 2014… Marriott CEO Arne Sorenson talks with Yahoo Finance about life after the hotel giant's major hacking incident.
March 21, 2018, 10:39:00 AM EDT By Zacks.com Shutterstock photo Key highlights of the week include Alexion gaining on positive data on PNH candidate, Arena surges on ulcerative drug data, Solid Biosciences' stock suffering a crash and Prothena teaming up with Celgene.
Exploring Arena Pharmaceuticals (NASDAQ:ARNA) stock? View ARNA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at
Panasonic Corporation ( パナソニック株式会社 , Panasonikku Kabushiki-gaisha), formerly known as Matsushita Electric Industrial Co., Ltd. ( 松下電器産業株式会社 , Matsushita Denki Sangyō Kabushiki-gaisha), is a Japanese multinational electronics…
Get today's Owens-Illinois Inc stock price and latest OI news as well as Owens-Illinois real-time stock quotes, technical analysis, full financials and more. obchodují na AMEX – American Stock Exchange. PowerShares jsou pečlivě vybírány prestižní investiční společností „Zacks Investment Research”. O co se jedná? PowerShares – PZI je v podstatě 390 akcií těch nejslibněji rostoucích ultra… Crowdsourced stock and analyst ratings and analysis for Zeltiq Aesthetics, Inc. ($ZLTQ) from the leading crowdsourced stock rating platform. Following the completion of the transaction, the insider now owns 524,755 shares of the company’s stock, valued at $2,524,071.55.
ARNA, Arena Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Zacks Equity Research 11/08/2019 02:56 AM ET ARNA | Complete Arena Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Get breaking news and analysis on Arena Pharmaceuticals, Inc. (ARNA) stock, price quote and chart, trading and investing tools. at Zacks.com (Nov 8, 2019).